We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
| CEO: |
Emma Walmsley |
| Non-Executive Director: |
Hal Barron , Wendy Becker , Jeannie Lee |
| Non-Executive Chairman: |
Jonathan Symonds |
| Senior Independent Non-Executive Director: |
Charles Bancroft |
| Chief Finance Officer: |
Julie Brown |
| Independent Non-Executive Director: |
Anne Beal, Harry (Hal) C. Dietz, Vishal Sikka, Jesse Goodman, Elizabeth (Liz) McKee Anderson |
| Address: |
79 New Oxford Street, London, United Kingdom |
| Phone: |
+44 (0)20 8047 5000 |
| Fax: |
|
| Website: |
http://www.gsk.com |
| Email: |
|